BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

402 related articles for article (PubMed ID: 17891620)

  • 21. Value of scar imaging and inotropic reserve combination for the prediction of segmental and global left ventricular functional recovery after revascularisation.
    Glaveckaite S; Valeviciene N; Palionis D; Skorniakov V; Celutkiene J; Tamosiunas A; Uzdavinys G; Laucevicius A
    J Cardiovasc Magn Reson; 2011 Jul; 13(1):35. PubMed ID: 21787383
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluation of left ventricular function three years after percutaneous recanalization of chronic total coronary occlusions.
    Kirschbaum SW; Baks T; van den Ent M; Sianos G; Krestin GP; Serruys PW; de Feyter PJ; van Geuns RJ
    Am J Cardiol; 2008 Jan; 101(2):179-85. PubMed ID: 18178403
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Nonstress delayed-enhancement magnetic resonance imaging of the myocardium predicts improvement of function after revascularization for chronic ischemic heart disease with left ventricular dysfunction.
    Schvartzman PR; Srichai MB; Grimm RA; Obuchowski NA; Hammer DF; McCarthy PM; Kasper JM; White RD
    Am Heart J; 2003 Sep; 146(3):535-41. PubMed ID: 12947375
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prognostic impact of contrast-enhanced CMR early after acute ST segment elevation myocardial infarction (STEMI) in a regional STEMI network: results of the "Herzinfarktverbund Essen".
    Bruder O; Breuckmann F; Jensen C; Jochims M; Naber CK; Barkhausen J; Erbel R; Sabin GV;
    Herz; 2008 Mar; 33(2):136-42. PubMed ID: 18344033
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Late gadolinium-enhanced cardiovascular magnetic resonance evaluation of infarct size and microvascular obstruction in optimally treated patients after acute myocardial infarction.
    Nijveldt R; Beek AM; Hofman MB; Umans VA; Algra PR; Spreeuwenberg MD; Visser CA; van Rossum AC
    J Cardiovasc Magn Reson; 2007; 9(5):765-70. PubMed ID: 17891613
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Do mechanical markers of myocardial ischaemia predict the transmural extent of myocardial infarction in man?
    Pingitore A; Rovai D; Positano V; Di Bella G; Strata E; De Marchi D; Passera M; Aquaro GD; Lombardi M
    J Cardiovasc Med (Hagerstown); 2006 Jun; 7(6):400-5. PubMed ID: 16721201
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Noninvasive diagnosis of coronary artery disease in patients with heart failure and systolic dysfunction of uncertain etiology, using late gadolinium-enhanced cardiovascular magnetic resonance.
    Soriano CJ; Ridocci F; Estornell J; Jimenez J; Martinez V; De Velasco JA
    J Am Coll Cardiol; 2005 Mar; 45(5):743-8. PubMed ID: 15734620
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Myocardial fibrosis as a key determinant of left ventricular remodeling in idiopathic dilated cardiomyopathy: a contrast-enhanced cardiovascular magnetic study.
    Masci PG; Schuurman R; Andrea B; Ripoli A; Coceani M; Chiappino S; Todiere G; Srebot V; Passino C; Aquaro GD; Emdin M; Lombardi M
    Circ Cardiovasc Imaging; 2013 Sep; 6(5):790-9. PubMed ID: 23934992
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of myocardial fibrosis and ventricular dyssynchrony on response to therapy in new-presentation idiopathic dilated cardiomyopathy: insights from cardiovascular magnetic resonance and echocardiography.
    Leong DP; Chakrabarty A; Shipp N; Molaee P; Madsen PL; Joerg L; Sullivan T; Worthley SG; De Pasquale CG; Sanders P; Selvanayagam JB
    Eur Heart J; 2012 Mar; 33(5):640-8. PubMed ID: 22048681
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prediction of long-term segmental and global functional recovery of hibernating myocardium after revascularisation based on low dose dobutamine and late gadolinium enhancement cardiovascular magnetic resonance.
    Glaveckaite S; Valeviciene N; Palionis D; Puronaite R; Serpytis P; Laucevicius A
    J Cardiovasc Magn Reson; 2014 Oct; 16(1):83. PubMed ID: 25279683
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Quantification of regional functional improvement of infarcted myocardium after primary PTCA by contrast-enhanced magnetic resonance imaging.
    Klug G; Trieb T; Schocke M; Nocker M; Skalla E; Mayr A; Nowosielski M; Pedarnig K; Bartel T; Moes N; Pachinger O; Metzler B
    J Magn Reson Imaging; 2009 Feb; 29(2):298-304. PubMed ID: 19161193
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Assessment of myocardial viability in ischemic heart disease by cardiac magnetic resonance imaging.
    Muellerleile K; Barmeyer A; Groth M; Lund GK
    Minerva Cardioangiol; 2008 Apr; 56(2):237-49. PubMed ID: 18319702
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cardiac magnetic resonance imaging predicts recovery of left ventricular function in acute onset cardiomyopathy.
    McLellan AJ; McKenzie SC; Taylor AJ
    Heart Lung Circ; 2012 Jan; 21(1):30-5. PubMed ID: 22055931
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of left ventricular scar size, location, and transmurality on left ventricular remodeling with healed myocardial infarction.
    Orn S; Manhenke C; Anand IS; Squire I; Nagel E; Edvardsen T; Dickstein K
    Am J Cardiol; 2007 Apr; 99(8):1109-14. PubMed ID: 17437737
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ischemic cardiomyopathy: value of different MRI techniques for prediction of functional recovery after revascularization.
    Van Hoe L; Vanderheyden M
    AJR Am J Roentgenol; 2004 Jan; 182(1):95-100. PubMed ID: 14684520
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Relationship between transmural extent of necrosis and quantitative recovery of regional strains after revascularization.
    Gerber BL; Darchis J; le Polain de Waroux JB; Legros G; Pouleur AC; Vancraeynest D; Pasquet A; Vanoverschelde JL
    JACC Cardiovasc Imaging; 2010 Jul; 3(7):720-30. PubMed ID: 20633850
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Extent of left ventricular scar predicts outcomes in ischemic cardiomyopathy patients with significantly reduced systolic function: a delayed hyperenhancement cardiac magnetic resonance study.
    Kwon DH; Halley CM; Carrigan TP; Zysek V; Popovic ZB; Setser R; Schoenhagen P; Starling RC; Flamm SD; Desai MY
    JACC Cardiovasc Imaging; 2009 Jan; 2(1):34-44. PubMed ID: 19356530
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prevalence, pattern, and functional impact of late gadolinium enhancement in left ventricular hypertrophy due to aortic valve stenosis.
    Nassenstein K; Bruder O; Breuckmann F; Erbel R; Barkhausen J; Schlosser T
    Rofo; 2009 May; 181(5):472-6. PubMed ID: 19241322
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prognostic value of myocardial viability by delayed-enhanced magnetic resonance in patients with coronary artery disease and low ejection fraction: impact of revascularization therapy.
    Gerber BL; Rousseau MF; Ahn SA; le Polain de Waroux JB; Pouleur AC; Phlips T; Vancraeynest D; Pasquet A; Vanoverschelde JL
    J Am Coll Cardiol; 2012 Feb; 59(9):825-35. PubMed ID: 22361403
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Magnetic resonance imaging in determination of myocardial ischemia and viability: comparison with positron emission tomography and single-photon emission computed tomography in a porcine model.
    Wang L; Zhu HY; Tian JM; Huang SD; Kong LS; Lu JP
    Acta Radiol; 2007 Jun; 48(5):500-7. PubMed ID: 17520425
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.